Skip to main content

Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program.

Journal articles  - Journal Article
Wang, N; DiCorpo, DA; Zhang, Y; Kleinbrink, E; Arnett, DK; Barnard, J; Blangero, J; Bowden, DW; Carson, AP; Chen, Y-DI; Chung, MK; Curran, JE ...
Published in: Diabetes
August 1, 2026

UNLABELLED: Large-scale multiancestry genome-wide association studies have identified hundreds of loci associated with type 2 diabetes (T2D) and glycemic traits, yet imputed genotyping arrays limit the detection of low-frequency and rare variants. Whole-genome sequencing (WGS) offers a more complete view of genetic variation, especially across diverse populations. We analyzed high-coverage (38×) WGS data from 21,913 T2D case subjects, 61,036 control subjects, and up to 50,011 individuals with no diabetes with fasting glucose, fasting insulin, and HbA1c from the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Program. We performed single-variant association testing, conditional analysis, fine-mapping, and Bayesian colocalization to identify genetic signals and assess regulatory relevance in diabetes-related tissues. We identified 76 distinct association signals across 34 loci, including novel variants at DUSP9 for T2D, and ROBO1, NDN, and MYT1 for HbA1c. Fine-mapping narrowed credible sets and improved causal variant resolution. Colocalization highlighted 80 expression signals in diabetes-related tissues, linking genetic associations to functional regulatory mechanisms. Our findings demonstrate the utility of WGS to uncover novel variants in diverse populations, enhance locus resolution, and link regulatory variation to disease-relevant tissues. This work refines the genetic architecture of T2D and glycemic traits and supports precision medicine efforts targeting diverse populations. ARTICLE HIGHLIGHTS: We aimed to improve understanding of the genetic architecture of type 2 diabetes and glycemic traits by leveraging whole-genome sequencing in diverse populations. Our goal was to identify novel variants, refine known loci, and link genetic signals to regulatory mechanisms through colocalization with expression quantitative trait loci. We discovered novel variants, significantly improved fine-mapping resolution, and identified 80 regulatory colocalization signals in diabetes-relevant tissues. These findings support precision medicine approaches by connecting genetic variation to functional biology in type 2 diabetes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Diabetes

DOI

EISSN

1939-327X

Publication Date

August 1, 2026

Volume

75

Issue

8

Start / End Page

1477 / 1491

Location

United States

Related Subject Headings

  • Whole Genome Sequencing
  • United States
  • Quantitative Trait Loci
  • Precision Medicine
  • Polymorphism, Single Nucleotide
  • National Heart, Lung, and Blood Institute (U.S.)
  • Middle Aged
  • Male
  • Humans
  • Glycated Hemoglobin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, N., DiCorpo, D. A., Zhang, Y., Kleinbrink, E., Arnett, D. K., Barnard, J., … NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium*. (2026). Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes, 75(8), 1477–1491. https://doi.org/10.2337/db25-0557
Wang, Ningyuan, Daniel A. DiCorpo, Yixin Zhang, Erica Kleinbrink, Donna K. Arnett, John Barnard, John Blangero, et al. “Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program.” Diabetes 75, no. 8 (August 1, 2026): 1477–91. https://doi.org/10.2337/db25-0557.
Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, Blangero J, Bowden DW, Carson AP, Chen Y-DI, Chung MK, Curran JE, Darbar D, Duggirala R, Ellinor PT, Fatkin D, Fornage M, Heard-Costa N, He J, Hou L, Kardia SLR, Kooperberg C, Loos RJF, McManus DD, Mitchell BD, Minster RL, North KE, Psaty BM, Raffield LM, Redline S, Rich SS, Roden D, Rotter JI, Shoemaker MB, Smith JD, Van Wagoner DR, Aguet F, Ardlie K, Bis JC, Brody JA, Cade BE, Clish CB, de Vries PS, Floyd JS, Freedman BI, Gabriel S, Gerzsten RE, Goodarzi MO, Gu C, Guo X, Gupta N, Heckbert SR, Hsu S, Hung Y-J, Kalyani RR, Kelly TN, Kinney GL, Li C, Liu S, Liu Y, Lloyd-Jones DM, Manson JE, Mathias RA, Mercader JM, Morrison AC, Naseri T, Onengut S, Palmer ND, Peyser PA, Qi Q, Raghavan S, Reiner AP, Rooney MR, Sevilla-Gonzalez M, Sarnowski C, Smith JA, Spartano NL, Tahir U, Taylor KD, Tobias DK, Tracy RP, Viali S, Wang H, Wood AC, Yanek LR, Zhao W, Zheng Y, Dupuis J, Liu C-T, Sladek R, Wessel J, Meigs JB, Manning AK, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium*. Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes. 2026 Aug 1;75(8):1477–1491.

Published In

Diabetes

DOI

EISSN

1939-327X

Publication Date

August 1, 2026

Volume

75

Issue

8

Start / End Page

1477 / 1491

Location

United States

Related Subject Headings

  • Whole Genome Sequencing
  • United States
  • Quantitative Trait Loci
  • Precision Medicine
  • Polymorphism, Single Nucleotide
  • National Heart, Lung, and Blood Institute (U.S.)
  • Middle Aged
  • Male
  • Humans
  • Glycated Hemoglobin